251. Effect of glucagon on insulin receptor substrate-1 (IRS-1) phosphorylation and association with phosphatidylinositol 3-kinase (PI 3-kinase).
- Author
-
Saad MJ, Hartmann LG, de Carvalho DS, Galoro CA, Brenelli SL, and Carvalho CR
- Subjects
- Animals, Insulin Receptor Substrate Proteins, Liver drug effects, Male, Muscle, Skeletal drug effects, Phosphatidylinositol 3-Kinases, Phosphoproteins drug effects, Phosphoproteins isolation & purification, Phosphorylation, Phosphotransferases (Alcohol Group Acceptor) drug effects, Phosphotyrosine, Rats, Reference Values, Tyrosine analogs & derivatives, Tyrosine metabolism, Glucagon pharmacology, Insulin pharmacology, Liver metabolism, Muscle, Skeletal metabolism, Phosphoproteins metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism
- Abstract
In the present study we have examined the levels and phosphorylation state of the insulin receptor and insulin receptor substrate 1 (IRS-1) as well as the association between IRS-1 and phosphatidylinositol 3-kinase (PI 3-kinase) in the liver and muscle of rats treated with glucagon. There was a decrease in the insulin-stimulated receptor and IRS-1 phosphorylation levels which was paralleled by a reduced association between IRS-1 and PI 3-kinase in vivo in the liver and muscle of glucagon-treated rats. These observations suggest that glucagon, probably acting through cAMP, may impair insulin signaling in the three early steps in insulin action after binding.
- Published
- 1995
- Full Text
- View/download PDF